Skip to content

Azora Therapeutics, Inc. (DE)

AZR· NasdaqCore metricsCIK 1513525

Pharmaceutical preparations552 peers

Close
Oct 29, 2026 · +48000.00%
Market cap
$12.63M
2.63M shares
Filings
583
—
—
—
-$64.56M
Q3 2026N/M FY25 yoy
-$7.53M
Q3 2026N/M FY25 yoy
-$12.01M
FY 2021derived
—
-$4.52
Q3 2026N/M FY25 yoy
$22.00M
Q3 2026+56.8% FY25 yoy
$12.63M
—
—
—
—
—

FY2025 figures · derived

Price

$4.81+48,000.00%+$4.80since Oct 28, 2026
Oct 29, 2026 · Official close
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$2.62MFY 2025
$8.40M0FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$2,619,671reported
FY 20242024-12-31$3,229,226reported
FY 20232023-12-31$1,267,077reported
FY 20222022-12-31$1,950,308 revisedreported
FY 20212021-12-31$8,395,648 revisedreported
FY 20202020-12-31$5,853,291reported
FY 20192019-12-31$3,965,543reported
FY 20182018-12-31$368,459reported
FY 20172017-12-31$182,107reported

Capital returns

Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2023—$1.66K$1.66K—4.05M sh−85.8%—

Pharmaceutical preparations

Azora Therapeutics, Inc. (DE) is the 406th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Azora Therapeutics, Inc. (DE) · CIK 1513525 · Engraved from SEC EDGAR